Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06442618
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-05-29
Brief Title:
Effectiveness of Extracorporeal Shockwave Therapy and Nutraceutical Supplementation in the Treatment of Epicondylitis a Clinical Trial
Sponsor:
University of Palermo
Organization:
University of Palermo
Study Overview
Official Title:
Effectiveness of Extracorporeal Shockwave Therapy and Nutraceutical Supplementation in the Treatment of Epicondylitis a Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Lateral epicondylitis is a pathologic condition of the musculotendinous system characterized by the presence of pain at the lateral epicondyle of the humerus it is a tendinopathy of the extensor muscles of the forearm often caused by overuse or repetitive use of the arm forced extension of the elbow or direct trauma to the humeral epicondyle This study evaluated the efficacy of Extracorporeal ShockWave Treatment ESWT combined with a supplemental nutraceutical treatment of Hyaluronic Acid Collagen Vitamin C and Manganese compared with single treatment in patients with lateral epicondylitis in term of improvement in pain functional capacity muscle strength and reduction of inflammation on ultrasound images A clinical trial was conducted at the UOC of Recovery and Functional Rehabilitation of AOUP P Giaccone of Palermo from Marc 2024 to July 2024 Patients were randomized into 3 groups in group A n 5 sessions of focal ESWT were given every six days in group B patients took daily for 30 days supplemental nutraceutical treatment of Hyaluronic Acid Collagen Vitamin C and Manganese and group C patients had combined treatment of ESWT one session every six days for a total of five sessions and nutraceutical supplementation one administration per day for one month All patients were evaluated at enrollment T0 after one month at the end of rehabilitation treatment T1 and at a follow up 30 days after the end of treatment T2 Researched will compare patients treated with ESWT or with nutraceutical treatment and patients who had combined treatment to see if there are real differences in term of pain reduction and improved short- and long-term quality of life
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None